Author

M. W. Nasser

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Assay:bulk RNA-seq· 3 Approach:statistical model· 3 Research Focus:drug response / drug discovery· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

S. K. Batra· 4 shared R. Chirravuri Venkata· 3 shared D. Doss· 2 shared I. Thapa· 2 shared N. Perumal· 2 shared S. Mahapatra· 2 shared A. K. Ganti· 1 shared A. Mohanty· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

S. K. Batra

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJan 24, 2022

Repressing ABCB7 Potentiates Cisplatin Response in Pediatric Group 3 Medulloblastoma by Triggering Ferroptosis

R. K. Kanchan, N. Perumal, P. Khan…·S. Mahapatra

This study shows that repressing ABCB7 in group 3 medulloblastoma triggers ferroptosis, enhancing cisplatin response and survival.

DOI 10.1101/2022.01.24.477587

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivApr 15, 2021

MiR-212-3p functions as a tumor suppressor gene in group 3 medulloblastoma via targeting Nuclear Factor I/B (NFIB)

N. Perumal, R. Kanchan, D. Doss…·S. Mahapatra

This study identifies miR-212-3p as a tumor suppressor in group 3 medulloblastoma by targeting NFIB, reducing cancer cell proliferation and metastasis.

DOI 10.1186/s40478-021-01299-z

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 29, 2020

1q21.3 amplification modulates therapy sensitivity in Triple-Negative Breast Cancer

R. Chirravuri Venkata, D. Ghersi, A. K. Ganti…·M. W. Nasser

The paper identifies 1q21.3 amplification as a genetic marker linked to therapy sensitivity in Triple-Negative Breast Cancer.

DOI 10.1101/2020.04.29.066993

humanwhole-genome sequencing

𝕏 PostBluesky

Cancer BiologybioRxivSep 25, 2019

A Non-genetic Mechanism for Chemoresistance in Lung Cancer: The Role of Integrin β4/Paxillin Axis

A. Mohanty, A. Nam, A. Pozhitkov…·R. Salgia

This study identifies a non-genetic mechanism for cisplatin resistance in lung adenocarcinoma involving the integrin β4/paxillin axis and its regulation of USP1 and VDAC1.

DOI 10.1016/j.isci.2020.101496

humanbulk RNA-seq

𝕏 PostBluesky